Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-18-000023
Filing Date
2018-01-05
Accepted
2018-01-05 16:16:21
Documents
2
Period of Report
2018-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151518696647616.html 4  
1 FORM 4 wf-form4_151518696647616.xml 4 3881
2 POWER OF ATTORNEY - ZELDIS ex-24.htm EX-24 4060
  Complete submission text file 0001070081-18-000023.txt   9386
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8767 E. VIA DE VENTURA, SUITE 190 SCOTTSDALE AZ 85258
Business Address
ZELDIS JEROME B (Reporting) CIK: 0001433982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 18513590